2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Design and personalisation of new upper-limb dynamic orthoses for dystonia and dyskinesia

L. Garavaglia, M. Ferari, A. Lo Mauro, E. Pagliano, G. Baranello, B. Bassi, A. Aliverti, S. Pittaccio (Lecco, Italy)
Design of a randomized, sham-controlled trial of pallidal neurostimulation versus botulinum toxin treatment for cervical dystonia (StimTox-CD)

H. Drechsel, U. Malzahn, C. Roeser, P. Heuschmann, J. Volkmann (Würzburg, Germany)
Detection of Early Changes in Microbiota Composition in Prodromal Parkinson’s Disease

J. Boertien, T. Van Laar (Groningen, Netherlands)
Determinant factors of treatment adherence in Parkinson’s disease

I. Estrada-Bellmann, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías, P. Cortés-Estrada (Monterrey, Mexico)
Determinants of balance confidence and concern about falling in people with Parkinson’s disease

L. Almeida, G. Valenca, E. Pinto, J. Oliveira-Filho (Salvador, Brazil)
Determinants of health-related quality of life in children and young adults with dystonia

H. Eggink, M. Coenen, A. Elema, W. Veenstra, K. Peall, D. Sival, M. Tijssen (Groningen, Netherlands)
Deutetrabenazine is Associated with an Improvement in Involuntary Movements in Patients With Tardive Dyskinesia as Seen by the High Proportion of Responders to Deutetrabenazine Treatment in the AIM-TD Study

J. Jimenez-Shahed, H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, W. Ondo, K. Anderson (Houston, TX, USA)
Deutetrabenazine Treatment Response by Concomitant Dopamine-Receptor Antagonists in the Phase III, Randomized, Double-Blind, Placebo-Controlled AIM-TD Trial in Tardive Dyskinesia

J. Jimenez-Shahed, H. Fernandez, D. Stamler, M. Davis, S. Factor, R. Hauser, J. Isojärvi, W. Ondo, K. Anderson (Houston, TX, USA)
Developing a guide to facilitate involving people with Parkinson’s and their carers in service improvement

N. Shaw, V. Evans, J. Rideout, C. Carroll (Plymouth, United Kingdom)
Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale

R. Fernandez-Bobadilla, S. Martinez-Horta, J. Marin-Lahoz, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z